BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18782308)

  • 1. The risks of long-term nitrofurantoin prophylaxis in patients with recurrent urinary tract infection: a recent medico-legal case.
    Cetti RJ; Venn S; Woodhouse CR
    BJU Int; 2009 Mar; 103(5):567-9. PubMed ID: 18782308
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung toxicity and Nitrofurantoin: the tip of the iceberg?
    Weir M; Daly GJ
    QJM; 2013 Mar; 106(3):271-2. PubMed ID: 22836192
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections.
    Madani Y; Mann B
    Prim Care Respir J; 2012 Sep; 21(3):337-41. PubMed ID: 22836745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrofurantoin-induced lung- and hepatotoxicity.
    Koulaouzidis A; Bhat S; Moschos J; Tan C; De Ramon A
    Ann Hepatol; 2007; 6(2):119-21. PubMed ID: 17519837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections.
    Schaeffer EM
    J Urol; 2013 Oct; 190(4):1252. PubMed ID: 24029321
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitrofurantoin toxicity to both liver and lungs.
    Yalçin S; Sahin A; Yalçin B; Altinok G
    Liver; 1997 Jun; 17(3):166-7. PubMed ID: 9249732
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver cirrhosis due to chronic use of nitrofurantoin].
    Volbeda F; Jonker AM; Vecht J; Groeneveld PH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(5):235-8. PubMed ID: 14983581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin].
    Lettgen B; Tröster K
    Klin Padiatr; 2002; 214(6):353-8. PubMed ID: 12424684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Milić R; Plavec G; Tufegdzić I; Tomić I; Sarac S; Loncarević O
    Vojnosanit Pregl; 2012 Jun; 69(6):536-40. PubMed ID: 22779302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent acute nitrofurantoin-induced pulmonary toxicity.
    Williams EM; Triller DM
    Pharmacotherapy; 2006 May; 26(5):713-8. PubMed ID: 16718946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrofurantoin-induced hepatotoxicity: a rare yet serious complication.
    Sakaan SA; Twilla JD; Usery JB; Winton JC; Self TH
    South Med J; 2014 Feb; 107(2):107-13. PubMed ID: 24926677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nitrofurantoin-induced lupus-like syndrome associated with hepatitis].
    Salle V; Lafon B; Smail A; Cévallos R; Chatelain D; Andréjak M; Ducroix JP
    Rev Med Interne; 2006 Apr; 27(4):344-6. PubMed ID: 16364504
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute kidney injury, hepatitis, and CPK elevation associated with nitrofurantoin therapy.
    Beigel R; Perets R; Mouallem M
    Am J Med Sci; 2009 Feb; 337(2):132-3. PubMed ID: 19214031
    [No Abstract]   [Full Text] [Related]  

  • 14. Nitrofurantoin-induced interstitial lung disease.
    Lin DC; Bhally H
    N Z Med J; 2007 Oct; 120(1263):U2753. PubMed ID: 17972973
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary toxicity resulting from the use of nitrofurantoin].
    Broes MJ; Roelofs BF; Mudde AH; Hoornenborg E
    Ned Tijdschr Geneeskd; 2012; 156(44):A4990. PubMed ID: 23114172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrofurantoin-induced immune-mediated lung and liver disease.
    Schattner A; Von der Walde J; Kozak N; Sokolovskaya N; Knobler H
    Am J Med Sci; 1999 May; 317(5):336-40. PubMed ID: 10334121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nitrofurantoin--clinical relevance in uncomplicated urinary tract infections].
    Stock I
    Med Monatsschr Pharm; 2014 Jul; 37(7):242-8. PubMed ID: 25065160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic eosinophilic pneumonia secondary to long-term use of nitrofurantoin: high-resolution computed tomography findings.
    Martins RR; Marchiori E; Viana SL; Grillo Júnior LS; Capelozzi VL; Valença LM
    J Bras Pneumol; 2008 Mar; 34(3):181-4. PubMed ID: 18392467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience.
    Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1998 Sep; 42(3):363-71. PubMed ID: 9786476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrofurantoin lung injury.
    Bidad K; Harries-Jones R
    Age Ageing; 2004 Jul; 33(4):414-5. PubMed ID: 15226112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.